Influenza Management Guide 2010-2011

• Published in: American family physician Vol. 82; no. 9; p. 1054
• Main Authors: Matin, Mina, MD, Goldschmidt, Ronald H., MD
• Format: Journal Article
• Language: English
• Published: United States American Academy of Family Physicians 01.11.2010
• Subjects: Antiviral Agents - therapeutic use; Centers for Disease Control and Prevention (U.S.); Disease management; Disease prevention; Health Personnel; Humans; Immunization; Immunization Programs - standards; Influenza Vaccines; Influenza, Human - diagnosis; Influenza, Human - drug therapy; Influenza, Human - prevention & control; Internal Medicine; Pandemics; Patients; Practice Guidelines as Topic; Prevention; Seasons; Swine flu; Triage; United States; Vaccines; Viruses; United States; San Francisco California; United States > US
• ISSN: 0002-838X; 1532-0650

The live intranasal vaccine continues to be contraindicated for some patient groups, including pregnant women, immunosuppressed patients, patients younger than two years or older than 50 years, and some patients with chronic medical conditions, such as asthma. Previous years' seasonal influenza viruses, conversely, had a reverse sensitivity profile that remained almost entirely resistant to oseltamivir and sensitive to adamantanes. Because questions remain about which viral strain will predominate this season, antiviral drug recommendations are not yet established. At the National HIV/AIDS Clinicians' Consultation Center (Warmline; 800-933-3413), based at San Francisco General Hospital, University of California, San Francisco, Department of Family and Community Medicine, we are following the trends closely via updates from the Centers for Disease Control and Prevention (http://www.cdc.gov/flu) and will continually revise our Influenza Management Guide this season (http://www.nccc.ucsf.edu).